BAC
Bank of America Corporation
BAC offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CBFV
CB Financial Services, Inc.
CBFV has a slight edge over BAC overall, supported by stronger fundamentals and stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
CBFV Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
CBFV's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like CBFV.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over CBFV in the historical PE scenario, which offers more potential upside but is not a forecast.
CBFV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.1x | $24.21 | -41% |
| Fair | 9.8x | $33.63 | -18% |
| Current | 12x | $41.10 | — |
| Forward | 12x | $41.10 | — |
| Expensive | 20x | $67.40 | +64% |
Historical ranges are pointers, not guarantees.
CBFV's PE is in its fair range at 12.0x. On analysts' estimates for next year's earnings, today's price would be 12.2x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over CBFV on the outlook, with more favorable valuation expectations.
CBFV Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CBFV, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over CBFV on earnings, with more consistent year-over-year improvement.
CBFV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.36 | -1.7% |
| Q3 2026 | $3.42 | +628% |
| Q2 2026 | $1.36 | -36% |
| Q1 2026 | $1.30 | -32% |
| Q4 2025 | $0.92 | -61% |
| Q3 2025 | $0.47 | -89% |
| Q2 2025 | $2.14 | -51% |
| Q1 2025 | $1.91 | -57% |
| Q4 2024 | $2.38 | -46% |
CBFV earned $3.42 per share over the past year, about seven times what it earned the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
CBFV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16M | +561% |
| Q2 2026 | $15.5M | +15% |
| Q1 2026 | $14.8M | +23% |
| Q4 2025 | $15.6M | +18% |
| Q3 2025 | $2.4M | -81% |
| Q2 2025 | $13.5M | +11% |
| Q1 2025 | $12.1M | -10% |
| Q4 2024 | $13.2M | -52% |
CBFV's revenue is recovering but still below its 2023 peak: $16M last quarter, up 561% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | +326 points |
| Q2 2026 | 33% | -2.1 points |
| Q1 2026 | 31% | +12 points |
| Q4 2025 | 34% | +11 points |
| Q3 2025 | -290% | -321 points |
| Q2 2025 | 35% | +8.6 points |
| Q1 2025 | 19% | -19 points |
| Q4 2024 | 23% | -43 points |
CBFV has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
CBFV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.8M | -161% |
| Q2 2026 | $7.4M | +90% |
| Q1 2026 | $2.8M | -28% |
| Q4 2025 | $4.8M | +267% |
| Q3 2025 | $4.5M | +104% |
| Q2 2025 | $3.9M | +$6.3M |
| Q1 2025 | $3.9M | +71% |
| Q4 2024 | $1.3M | +$6.4M |
CBFV has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over CBFV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
CBFV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +4.1K shares |
| 1 year | +0.7% | +38.5K shares |
| 3 years | +4.5% | +232K shares |
| 5 years | -0.6% | -32.1K shares |
| Available history | -1.7% | -90.7K shares |
CBFV has 5M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $9,000 |
| Q2 2026 | $14,000 |
| Q1 2026 | $292,000 |
| Q4 2025 | $14,000 |
| Q3 2025 | $7,000 |
| Q2 2025 | $4.4M |
| Q1 2025 | $2.4M |
| Q4 2024 | $634,000 |
CBFV spent $329,000 buying back its own shares over the past year, down 96% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
CBFV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q2 2026 | 2.4x | Moderate |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | 5.4x | High |
| Q3 2025 | -4.3x | Net Cash |
| Q2 2025 | -1.9x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | 1.1x | Healthy |
CBFV has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
CBFV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.0 | Overbought |
| Stochastic | 89.3 | Overbought |
CBFV's weekly RSI is 71 (overbought) and its Stochastic is 89 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
CBFV PE vs Financial Services Sector
| Metric | CBFV | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.7% below |
| PE % | 63 | 63 | Same percentile |
CBFV has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
CBFV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.6 | 6.5% above |
| 20 week MA | $37.7 | 8.9% above |
| 50 week MA | $36.4 | 13% above |
| 100 week MA | $33.3 | 23% above |
| 200 week MA | $28.3 | 45% above |
CBFV has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
CBFV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.6 | $20.3 | -34% |
| 2021 | $20.3 | $23.9 | +18% |
| 2022 | $23.9 | $21.3 | -11% |
| 2023 | $21.3 | $23.8 | +12% |
| 2024 | $23.8 | $28.7 | +20% |
| 2025 | $28.7 | $36.0 | +25% |
| 2026 YTD | $36.0 | $41.1 | +14% |
CBFV has the edge over BAC on returns for 2026, with the stronger performance.